Use of Bayesian Net Benefit Regression Model to Examine the Impact of Generic Drug Entry on the Cost Effectiveness of Selective Serotonin Reuptake Inhibitors in Elderly Depressed Patients

By Ya-Chen Tina Shih   Bekele Nebiyou B.   Xu Ying  

PharmacoEconomics, Vol. 25, Iss. 10, 2007-01 ,pp. : 843-862

Adis International

Access to resources Recommend Favorite

Cost Considerations in the Use of Anaesthetic Drugs

By Smith I.  

PharmacoEconomics, Vol. 19, Iss. 5, 2001-01 ,pp. : 469-481

Adis International

Access to resources Recommend Favorite

The cost offsets and cost-effectiveness associated with pegylated drugs: a review of the literature

By Becker Russell   Dembek Carole   White Leigh Ann   Garrison Louis P  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 12, Iss. 6, 2012-12 ,pp. : 775-793

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Venlafaxine Compared with Generic Fluoxetine or Generic Amitriptyline in Major Depressive Disorder in the UK

By Lenox-Smith Alan  

Clinical Drug Investigation, Vol. 29, Iss. 3, 2009-02 ,pp. : 173-184

Adis International

Access to resources Recommend Favorite

Valuing Health States for Use in Cost-Effectiveness Analysis

By Brazier John  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 769-779

Adis International

Access to resources Recommend Favorite